Biological evaluation of signal transducer and activator of transcription 3 (STAT3) targeting by phaeosphaeride A and its analogs

Bioorg Med Chem Lett. 2024 Dec 1:114:130004. doi: 10.1016/j.bmcl.2024.130004. Epub 2024 Oct 18.

Abstract

The inhibitory activities of phaeosphaeride A (PPA), phaeosphaeride B, and four synthetic derivatives against phosphorylation of signal transducer and activator of transcription 3 (STAT3) and cell proliferation in cervical (HeLa) and breast (MDA-MB-231) cancer cells were evaluated. PPA inhibited IL-6-induced STAT3 phosphorylation and cell proliferation at similar concentrations. The structure-activity relationship studies revealed that the enantiomer of PPA was the most potent of the evaluated phaeosphaerides in both inhibiting STAT3 phosphorylation and cell growth. PPA clearly inhibited the IL-6-activated STAT3 signaling pathway. However, the presence or absence of activation of the STAT3 signaling pathway in cells showed no relationship to the antiproliferative activity. Notably, the possible covalent bond-forming ability of PPA was critical for its biological activities.

Keywords: Natural product; Phaeosphaeride A; Signal transducer and activator of transcription 3; Structure–activity relationship.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • HeLa Cells
  • Humans
  • Interleukin-6 / antagonists & inhibitors
  • Interleukin-6 / metabolism
  • Molecular Structure
  • Phosphorylation / drug effects
  • STAT3 Transcription Factor* / antagonists & inhibitors
  • STAT3 Transcription Factor* / metabolism
  • Signal Transduction / drug effects
  • Structure-Activity Relationship

Substances

  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Antineoplastic Agents
  • Interleukin-6